Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: EC:3.2.1.23 (beta-galactosidase)
 14,648 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

A tryptophan-requiring strain of Escherichia coli can go through two doublings of optical density after L-tryptophan is replaced in the medium by 4-fluorotryptophan, during which the fluoro analog displaces approximately 75% of the L-tryptophan in cell protein. One doubling occurs in the presence of 5- or 6-fluorotryptophan, with 50-60% replacement of L-tryptophan by analog. When beta-galactosidase is induced at the time of addition of analog, it reaches 60% of the control specific activity in the presence of 4-fluorotryptophan, 10% of normal in the presence of 5- or 6-fluorotryptophan. Lactose permease activity is 35% of the control in the presence of 4- and 6-fluorotryptophan, less than 10% in the presence of 5-fluorotryptophan. D-Lactate dehydrogenase shows a specific activity twice that of the control in the presence of 4-fluorotryptophan, one-half with 5- or 6-fluorotryptophan. Thus fluorotryptophan can be incorporated into proteins and affect their activities, although the nature and magnitude of the effect cannot be predicted for any given enzyme. Such substituted proteins should be useful for the study of protein structure and function by 19F nuclear magnetic resonance and other techniques.
 ...
PMID:Incorporation of fluorotryptophans into proteins of escherichia coli. 109 37

Allogeneic bone marrow transplantation was carried out in an 81-day-old Portuguese water dog with GM1 gangliosidosis using a DLA identical sibling as donor. Engraftment was complete and beta-galactosidase activity in leukocytes of the transplanted dog were similar to those in the donor. Over the next 2.5 months neurological deterioration in the transplanted dog was similar to that in untreated dogs with GM1 gangliosidosis. Cerebral ganglioside GM1 concentrations were not diminished by bone marrow transplantation and cerebral beta-galactosidase activity was negligible. We conclude that allogeneic bone marrow transplantation early in life is ineffective in canine GM1 gangliosidosis.
 ...
PMID:Bone marrow transplantation in canine GM1 gangliosidosis. 212 50